Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000465495 | SCV000556529 | benign | Tuberous sclerosis 2 | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001014071 | SCV001174735 | likely benign | Hereditary cancer-predisposing syndrome | 2018-06-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001091436 | SCV001788490 | likely benign | not provided | 2021-09-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000465495 | SCV002041189 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002477139 | SCV002795652 | likely benign | Lymphangiomyomatosis; Isolated focal cortical dysplasia type II; Tuberous sclerosis 2 | 2022-01-09 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000043366 | SCV004816924 | likely benign | Tuberous sclerosis syndrome | 2024-09-23 | criteria provided, single submitter | clinical testing | |
Tuberous sclerosis database |
RCV000043366 | SCV000067172 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |